C4 therapeutics to participate in upcoming september investor conferences

Watertown, mass., aug. 29, 2024 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that c4t management will participate in fireside chats at two september investor conferences.
CCCC Ratings Summary
CCCC Quant Ranking